日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modelling adipose tissue-cancer crosstalk: a three-dimensional perspective

脂肪组织与癌症相互作用的三维建模视角

Strusi, Gabriele; Suelzu, Caterina M; Stebbing, Justin

Cancer-associated fibroblasts as key regulators of lipid metabolism in the tumour microenvironment

癌相关成纤维细胞是肿瘤微环境中脂质代谢的关键调节因子

Adams, Jessamy; Suelzu, Caterina M; Strusi, Gabriele; Stebbing, Justin

Toward Sustainable Adsorbents for CO(2) Capture: Reuse of Silica from Spent Silica-Polyethylenimine

面向可持续二氧化碳捕集吸附剂:废硅聚乙烯亚胺中二氧化硅的再利用

Li, Wei; Stevens, Lee; Stefanidis, Stylianos D; Lappas, Angelos; Fabbri, Daniele; Mazzocchetti, Laura; Coralli, Irene; Stebbing, Simon; Snape, Colin E

Reported Availability, Additional Cost and Use of Methods to Limit Cross-Contact of Gluten-Free Foods in Restaurants in a Canadian Large Urban Centre

加拿大某大型城市中心餐厅中无麸质食品的供应情况、额外成本及限制交叉污染方法的使用情况报告

Defries, Danielle; Danchuk, Caitlynn; Stebbing, Jo-Ann; Petkau, Jay C; Blewett, Heather

The Impact of Study Size on COVID-19 Treatment Outcomes: A Meta-Epidemiological Study Comparing Large and Small Randomized Controlled Trials: A Systematic Review and Meta-Analyses

研究规模对 COVID-19 治疗结果的影响:一项比较大型和小型随机对照试验的荟萃流行病学研究:系统评价和荟萃分析

Kim, Dong Hyun; Lim, Soojin; Eisenhut, Michael; Kronbichler, Andreas; Kim, Eunyoung; Kim, Min Seo; Papatheodorou, Stefania I; Stebbing, Justin; Peng, Yonghong; Oh, Sarah Soyeon; Shin, Jae Il; Smith, Lee

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas

Botensilimab(Fc增强型抗细胞毒性淋巴细胞相关蛋白-4抗体)联合Balstilimab(抗PD-1抗体)治疗复发/难治性转移性肉瘤患者

Wilky, Breelyn A; Schwartz, Gary K; Gordon, Michael S; El-Khoueiry, Anthony B; Bullock, Andrea J; Henick, Brian; Agulnik, Mark; Singh, Arun; Mahadevan, Daruka; Stebbing, Justin; Delepine, Chloe; Chand, Dhan; Avagyan, Manushak; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven; Trent, Jonathan C; Jones, Robin L; Tsimberidou, Apostolia M

Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer

在难治性卵巢癌患者中,Botensilimab(Fc增强型抗CTLA-4抗体)联合balstilimab(抗PD-1抗体)治疗方案

Porter, Rebecca; Bockorny, Bruno; Corr, Bradley R; Mahadevan, Daruka; Wilky, Breelyn A; El-Khoueiry, Anthony B; Bullock, Andrea J; Hafez, Navid; Moser, Justin; Martynova, Anastasia; Stebbing, Justin; Joshi, Bishnu; Bourdelais, Sean; Delepine, Chloe; Chand, Dhan; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven J; Matulonis, Ursula A; Gordon, Michael S

CD47 as a potential predictive biomarker in colorectal cancer

CD47作为结直肠癌的潜在预测生物标志物

Stebbing, Justin; Bullock, Andrea

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

PREDICT全球汇总分析中重复循环肿瘤细胞计数作为转移性乳腺癌早期治疗监测工具的临床有效性

Janni, Wolfgang; Friedl, Thomas W P; Yab, Tracy C; Bidard, Francois-Clément; Cristofanilli, Massimo; Hayes, Daniel F; Ignatiadis, Michail; Regan, Meredith M; Alix-Panabieres, Catherine; Barlow, William E; Caldas, Carlos; Carey, Lisa A; Dirix, Luc; Fehm, Tanja; Garcia-Saenz, Jose A; Gazzaniga, Paola; Generali, Daniele; Gerratana, Lorenzo; Gisbert-Criado, Rafael; Jacot, William; Jiang, Zefei; Joosse, Simon A; Lianidou, Evi; López López, Rafael; Magbanua, Mark J M; Manso, Luis; Mavroudis, Dimitris; Müller, Volkmar; Munzone, Elisabetta; Pantel, Klaus; Pierga, Jean-Yves; Rack, Brigitte; Riethdorf, Sabine; Rugo, Hope S; Sideras, Kostandinos; Sleijfer, Stefan; Smerage, Jeffrey; Stebbing, Justin; Terstappen, Leon W M M; Vidal-Martínez, Jose; Wallwiener, Markus; Giridhar, Karthik V; Liu, Minetta C

The Relationship Between Response Rate and Survival Benefits in Randomized Immunotherapy Studies

随机免疫治疗研究中应答率与生存获益之间的关系

Jain, Aditi; Stebbing, Justin